At approximately how many weeks of gestation can the sex of the fetus be identified through ultrasound
fetal sex determination ultrasound weeks gestation accuracy
"Ultrasound examination can be used to determine fetal sex as early as 13 weeks of gestation."
| Gestational Age | Reliability |
|---|---|
| 11-12 weeks | ~65% identification rate; variable accuracy |
| 12-14 weeks | High accuracy (99.6% male, 97.4% female in research settings) |
| 18-20 weeks | Most reliable - standard anatomy scan |
| 16-40 weeks | ~99.8% overall accuracy |
6. Question: Diclofenac sodium is commonly used to manage pain and inflammation but is contraindicated in individuals with: A) Hypothyroidism B) Asthma C) Ischemic heart disease D) Peptic ulcer diseas
diclofenac sodium contraindications peptic ulcer NSAID
"Prostaglandins promote gastric and duodenal mucosal protection from luminal acid and pepsin via numerous mechanisms, including increasing mucin and bicarbonate secretion, increasing blood flow to the mucosal endothelium, and promoting epithelial cell proliferation and migration to the luminal surface. NSAIDs disrupt [this protection]..."
"NSAIDs, including aspirin, predominantly cause ulceration by inhibiting cyclooxygenase (COX)-mediated prostaglandin synthesis which impairs mucosal protection... Gastroduodenal ulcers are found at endoscopy in 1-45% of patients who take NSAIDs regularly."
| Option | Verdict | Reason |
|---|---|---|
| A) Hypothyroidism | Not a contraindication | No known pharmacological interaction with diclofenac |
| B) Asthma | Caution, not absolute contraindication | Aspirin-exacerbated respiratory disease (AERD) is the concern, but this applies primarily to aspirin and some NSAIDs; it is a precaution, not a primary standard contraindication listed for diclofenac in most exams |
| C) Ischemic heart disease | Relevant risk, but not the classic answer | NSAIDs do carry cardiovascular risk; diclofenac is contraindicated after CABG surgery specifically. However, for exam purposes, peptic ulcer disease is the textbook primary contraindication |
| D) Peptic ulcer disease | CORRECT | Blockade of COX-1 removes gastric mucosal protection, directly worsening or precipitating ulcers |
Note: In clinical practice, diclofenac and all NSAIDs carry both GI and cardiovascular warnings. Ischemic heart disease is increasingly recognised as a contraindication (especially post-MI), but peptic ulcer disease remains the classic, primary contraindication tested in pharmacology exams.
estion: Hyperplasia refers to an increase in the number of cells. What term refers to a decrease in cell number? A) Hypertrophy B) Hypoplasia C) Aplasia D) Atrophy
hypoplasia definition decrease cell number vs hyperplasia pathology
| Prefix | Meaning | Suffix | Full Term | Definition |
|---|---|---|---|---|
| hyper- | over / above normal | -plasia (cell formation) | Hyperplasia | Increase in cell number |
| hypo- | under / below normal | -plasia | Hypoplasia | Decrease in cell number |
"Hyperplasia is an increase in the number of cells in an organ that stems from increased proliferation, either of differentiated cells or, in some instances, progenitor cells."
| Option | Term | Definition | Why It's Wrong |
|---|---|---|---|
| A) Hypertrophy | Increase in cell size (not number) | Individual cells enlarge without dividing | Describes size change, not number |
| B) Hypoplasia | Decrease in cell number ✓ | Under-development or reduction of cells | CORRECT answer |
| C) Aplasia | Complete absence of cell production | No cells formed at all (e.g., aplastic anaemia) | This is an extreme/total failure, not simply a decrease |
| D) Atrophy | Decrease in cell size (and sometimes number secondarily) | Cells shrink due to reduced workload or nutrition | Primarily about size reduction, not a direct decrease in number |
delayed wound healing process is often associated with: A) Infection 7 BPSC NUGGETS by Dr. Israr Roshan B) Excessive scarring C) Poor nutrition D) Chronic inflammation
delayed wound healing most common cause associated factors pathology
"Several local and systemic factors affect the inflammatory phase of wound healing directly. These include pressure, tissue hypoxia, infection, tissue contamination, desiccation, and maceration... The common thread in all nonhealing chronic wounds is the persistence of proinflammatory conditions."
"Poor nutrition is associated with decreased wound healing, compromised immunity, organ dysfunction, increases in infection, and mortality."
"Local factors include inadequate blood supply, necrotic tissue, increased proteolytic activity, mechanical irritation, pressure, bacterial components, local toxins, and growth factor deficiency."
| Option | Role in Delayed Healing | Classification |
|---|---|---|
| A) Infection | Bacteria trigger persistent inflammation, destroy new tissue, degrade matrix proteins, and prevent progression to proliferation/remodelling | Most direct LOCAL cause |
| B) Excessive scarring | This is a consequence of abnormal healing, not a cause of delay | Wrong - this is a result, not a cause |
| C) Poor nutrition | Deficiencies (protein, Vitamin C, zinc) impair collagen synthesis and immunity | Systemic cause - important but less direct |
| D) Chronic inflammation | Persistent inflammation does delay healing - but it is often itself caused by infection | Mechanism, not primary cause |
Final Answer: A) Infection - the single most common and direct cause of delayed wound healing, acting through persistent inflammation and tissue destruction.
If you have received the yellow fever vaccine and plan to travel to an African country with a risk of yellow fever transmission, how long should you wait before your trip? A. 24 hours B. 48 hours C. 7 days D. 30 days
yellow fever vaccine how many days before travel immunity effective WHO CDC
"The International Certificate of Vaccination or Prophylaxis (ICVP) becomes valid beginning 10 days after the date of primary vaccination." - CDC Yellow Book
"The yellow fever vaccine provides immunity within one week (7 days) in 95% of people vaccinated." - WHO
"Travelers who receive YF vaccine <10 days before entering a risk area are at risk of infection with YF virus." - CDC, Last-Minute Travelers
"The vaccine provides effective immunity within 10 days for 80-100% of those vaccinated, and within 30 days for more than 99%."
| Timeframe | What Happens |
|---|---|
| Within 7 days | 95% of vaccinees develop immunity (WHO figure) |
| 10 days | ICVP certificate becomes legally valid; official WHO/CDC threshold for travel |
| 30 days | >99% immunity achieved |
Best answer from the given options: C) 7 days - though the true internationally recognised threshold is 10 days.
Medication which may prevent the rapid progress of Cochlear Otosclerosis? A. Steroids B. Antibiotics C. Fluorides D. Vitamins
sodium fluoride cochlear otosclerosis progression prevention mechanism
"Sodium fluoride has been used for 35 years in an attempt to slow down or arrest sensorineural hearing loss in patients with stapedial otosclerosis or after stapedectomy. It has also been used in patients with 'pure' cochlear otosclerosis."
"Sodium fluoride is an enzyme inhibitor and reduces osteoclastic bone resorption... sodium fluoride influenced the underlying bony changes in the labyrinth so as to arrest or prevent the onset of hearing loss."
"Sodium fluoride is a known inhibitor of osteoclast activity and so a stabilizer of bone turnover. It also leads to increased calcium deposition in otospongiotic foci and decreased bone remodelling. The release of cytokines from bony remodelling adjacent to the cochlear spiral ligament may be responsible for the sensorineural hearing loss sometimes seen in otosclerosis. Sodium fluoride has the potential to reduce this."
| Option | Verdict | Reason |
|---|---|---|
| A) Steroids | Not used for cochlear otosclerosis progression | Steroids have no role in slowing otosclerosis; used in sudden SNHL from other causes |
| B) Antibiotics | Irrelevant | Otosclerosis is a bone remodelling disorder, not an infection |
| C) Fluorides | CORRECT | Sodium fluoride inhibits osteoclast enzymes, stabilises bone turnover, reduces cytokine release near the cochlea |
| D) Vitamins | Not a recognised treatment | No evidence vitamins slow cochlear otosclerosis progression |
Why spirolectone cause gynaecomastia
spironolactone gynecomastia mechanism androgen receptor estrogen
"Drugs can cause gynecomastia by... inhibiting androgen synthesis (e.g., GnRH agonists, ketoconazole) or action (e.g., spironolactone, AR blockers such as enzalutamide)."
Spironolactone
│
├─► Blocks androgen receptors in breast ──────────────────┐
│ ▼
├─► Inhibits testosterone synthesis (17α-OH, 17,20-DL) Oestrogen:Androgen
│ ratio ↑
├─► Increases androgen→oestrogen aromatisation ──────────►│
│ │
└─► Displaces oestradiol from SHBG (raises free E₂) ─────►│
▼
Glandular breast proliferation
= GYNAECOMASTIA
If left untreated, a patient with otitis media can develop which of the following complications? A) Tinnitus B) Conductive hearing loss C) Vertigo D) Mastoiditis
otitis media untreated complications mastoiditis conductive hearing loss
"Mastoiditis is the most common suppurative complication of otitis media, although the incidence of acute and chronic mastoiditis has decreased significantly since the advent of antibiotics."
"The middle ear and mastoid air cells are connected by the aditus ad antrum. If this narrow connection becomes obstructed, a closed space is formed with the potential for mastoid abscess development and bone destruction. Infection may spread from the mastoid air cells by venous channels, resulting in inflammation of the overlying periosteum. Progression results in the destruction of the mastoid bone trabeculae and coalescence of the cells, resulting in acute mastoid osteitis or coalescent mastoiditis."
| Option | Verdict | Explanation |
|---|---|---|
| A) Tinnitus | Not a classic complication | Tinnitus is a symptom that can occur with middle ear disease, but is not a recognised complication of untreated otitis media |
| B) Conductive hearing loss | Associated, but not a "complication" | Hearing loss occurs during active otitis media (fluid in middle ear) but is expected and usually resolves - it is a feature, not a complication of leaving it untreated |
| C) Vertigo | Not a primary complication | Vertigo occurs if infection spreads to the labyrinth (labyrinthitis), which is itself a complication of untreated mastoiditis, not directly of otitis media |
| D) Mastoiditis | CORRECT | The most common suppurative complication of untreated otitis media - infection spreads directly from the middle ear through the aditus ad antrum to the mastoid air cells |
Otitis Media (untreated)
│
▼
Mastoiditis ← most common first complication
│
├──► Subperiosteal abscess
├──► Bezold abscess (neck)
├──► Labyrinthitis → vertigo/SNHL
├──► Facial nerve palsy
├──► Meningitis
└──► Brain abscess (most serious)
What is the drug of choice for reperfusion therapy in myocardial infarction (MI)? A) Aspirin B) Heparin C) Nitroglycerin D) Thrombolytics (e.g., alteplase
drug of choice reperfusion therapy STEMI thrombolytics vs PCI guidelines
"The majority of patients who suffer an acute STEMI have thrombotic occlusion of a coronary artery. Early restoration of coronary perfusion limits infarct size, preserves LV function, and reduces mortality. All other therapies are secondary and should not delay the timely goal of achieving coronary reperfusion."
"Unless spontaneous resolution of ischemia occurs, the choice of reperfusion strategy includes thrombolysis, primary PCI, or emergent CABG."
| Reperfusion Method | Type | When Preferred |
|---|---|---|
| Primary PCI | Procedure (not a drug) | PCI available within 90-120 min |
| Thrombolytics (alteplase, tenecteplase, streptokinase) | Drug | PCI not available in time; within 12 hrs of symptom onset |
| Option | Role in MI | Why Not "Reperfusion" |
|---|---|---|
| A) Aspirin | Antiplatelet - prevents further clot formation | Does NOT dissolve existing clot or restore flow |
| B) Heparin | Anticoagulant - adjunct therapy | Prevents new clot extension but does NOT dissolve existing clot |
| C) Nitroglycerin | Vasodilator - relieves ischaemic pain, reduces preload | Does NOT open an occluded coronary artery |
| D) Thrombolytics | CORRECT - dissolves the thrombus occluding the coronary artery | Directly restores blood flow = reperfusion |
Key exam point: Thrombolytics = pharmacological reperfusion. Aspirin and heparin = adjunct/supportive therapy. Nitroglycerin = symptom relief only.
Horner syndrome is characterized by which of the following symptoms? A) Ptosis (drooping eyelid) B) Exophthalmos (protrusion of the eyeball) C) Diplopia (double vision) D) Miosis (constricted pu
"The triad of miosis with ipsilateral ptosis and anhidrosis constitutes Horner's syndrome, although anhidrosis is an inconstant feature."
"Horner's syndrome is characterized by a triad of symptoms: miosis (constriction of the pupil), partial ptosis (drooping of the superior eyelid), and anhidrosis (absence of sweating)."
"The hallmark of Horner syndrome is the triad of anhidrosis, ptosis, and miosis. Symptoms also include enophthalmos (sunken eyeball) and vasodilation."
| Feature | Description | Mechanism |
|---|---|---|
| Miosis | Constricted pupil | Loss of sympathetic innervation to dilator pupillae muscle; unopposed parasympathetic constriction |
| Ptosis | Partial drooping of upper eyelid | Paresis of Müller's muscle (superior tarsal muscle), which is sympathetically innervated |
| Anhidrosis | Reduced/absent sweating on affected side of face | Loss of sympathetic innervation to sweat glands |
| Enophthalmos | Sunken eyeball (apparent) | Loss of tone in orbitalis muscle |
| Reverse ptosis | Slight elevation of lower eyelid | Loss of sympathetic tone in inferior tarsal muscle |
| Option | Verdict | Reason |
|---|---|---|
| A) Ptosis | Correct feature - but partial/mild ptosis, not complete | However, if forced to choose ONE answer, miosis is the most pathognomonic and distinguishing sign |
| B) Exophthalmos | WRONG | Exophthalmos (bulging eye) is the opposite - Horner causes enophthalmos (sunken eye). Exophthalmos is seen in Graves' disease/hyperthyroidism |
| C) Diplopia | WRONG | Double vision results from CN III, IV, or VI palsy - not from sympathetic pathway disruption |
| D) Miosis | CORRECT | Constricted pupil is the most characteristic and diagnostically important sign of Horner syndrome |
Memory aid - "PAM": Ptosis + Anhidrosis + Miosis = Horner Syndrome. All caused by disruption of the 3-neuron sympathetic pathway (hypothalamus → ciliospinal centre of Budge → superior cervical ganglion → eye).
A patient presents with a central loss of vision. On examination, a lesion is found in the macula. Which condition is most likely responsible for this presentation? A) Macular degeneration B) Glaucoma C) Optic neuritis D) Retinal detachment Answer
"Over time, central vision gradually diminishes, impairing reading, but these patients can navigate because of retained peripheral vision. Examination discloses a central scotoma with pigmentary changes in the region around the macula."
| Option | Visual Field Loss | Lesion Location | Verdict |
|---|---|---|---|
| A) Macular degeneration | Central loss - scotoma | Macula itself - directly matches the question | CORRECT |
| B) Glaucoma | Peripheral loss first (arcuate/nasal step) then "tunnel vision" | Optic nerve head (raised IOP) | Wrong - peripheral not central |
| C) Optic neuritis | Central scotoma possible, but also affects whole visual field; painful | Optic nerve (demyelination) | Not a macular lesion |
| D) Retinal detachment | Peripheral curtain/shadow, progressing centrally | Retinal separation (usually peripheral first) | Not primarily a macular lesion |
| Type | Features |
|---|---|
| Dry (atrophic) - 85% | Drusen deposits, slow RPE atrophy, gradual central vision loss |
| Wet (neovascular/exudative) - 15% | Choroidal neovascularisation, rapid central vision loss, distortion (metamorphopsia) |
Glaucoma → Peripheral loss → "Tunnel vision"
Macular disease → Central loss → "Scotoma/Blurred centre"
Optic neuritis → Central loss → Painful, young patient, MS association
Retinal detach. → Curtain/shadow → "Like a curtain being drawn"
Homonymous → Half field → Post-chiasmal lesion (stroke, tumour)
The question is designed to test that you link "macula lesion" directly to "central vision loss" and "macular degeneration" - the only condition among the choices that primarily and specifically affects the macula itself.
Adenoids are also known as: A) Palatine tonsils B) Lingual tonsils C) Pharyngeal tonsils D) Tubal tonsils Answ
"The pharyngeal tonsil, known as adenoids when enlarged, is in the midline on the roof of the nasopharynx."
"They, along with the pharyngeal tonsils (adenoids) and lingual tonsils, form a ring at the entrance to the oropharynx (Waldeyer's ring)."
| Tonsil | Also Known As | Location |
|---|---|---|
| Pharyngeal tonsil | Adenoids | Roof/posterior wall of nasopharynx |
| Palatine tonsils | "The tonsils" (common usage) | Between palatoglossal and palatopharyngeal arches in oropharynx |
| Lingual tonsils | - | Base of tongue |
| Tubal tonsils | - | Around opening of Eustachian tube in nasopharynx |
| Option | Verdict | Reason |
|---|---|---|
| A) Palatine tonsils | Wrong | These are the tonsils seen when you open your mouth - on either side of the oropharynx. Commonly removed in tonsillectomy |
| B) Lingual tonsils | Wrong | Located at the base of the tongue |
| C) Pharyngeal tonsils | CORRECT | = Adenoids; on the roof of the nasopharynx |
| D) Tubal tonsils | Wrong | Small lymphoid tissue near the Eustachian tube opening; not the adenoids |
Key fact: Adenoids are only called "adenoids" when they are enlarged (hypertrophied). The correct anatomical term is always pharyngeal tonsil. In children, enlarged adenoids can obstruct the nasopharynx causing mouth breathing, snoring, and nasal speech.
patient presents with sudden loss of vision and a red eye. Which condition is most likely responsible for these findings? A) Glaucoma B) Retinal detachment C) Cataract D) Conjunctivitis
Eye Pain Onset Other Findings Yes Sudden Painful red eye, hazy cornea, midpoint pupil, narrow anterior chamber, firm globe
"Unlike the more common open-angle glaucoma, acute glaucoma usually comes on rapidly. The most common symptom is severe pain in one eye. The patient complains of impaired vision and halos around lights."
| Feature | Finding |
|---|---|
| Vision | Sudden, severe loss - blurred/misty |
| Eye appearance | Red eye (ciliary flush/conjunctival injection) |
| Pain | Severe, aching eye pain ± headache |
| Pupil | Mid-dilated, fixed, non-reactive |
| Cornea | Hazy/steamy (corneal oedema from raised IOP) |
| IOP | Markedly elevated (may be >50 mmHg; normal <21 mmHg) |
| Associated symptoms | Nausea, vomiting, halos around lights |
| Option | Red Eye? | Sudden Vision Loss? | Verdict |
|---|---|---|---|
| A) Glaucoma (acute angle-closure) | YES | YES | CORRECT - both features present |
| B) Retinal detachment | NO | Yes (painless) | Red eye is absent; painless "curtain/shadow" vision loss |
| C) Cataract | No | No (gradual over months-years) | Neither feature - gradual, painless clouding |
| D) Conjunctivitis | YES | NO | Red eye present but vision is NOT lost |
Red eye ALONE → Conjunctivitis, episcleritis, uveitis
Sudden vision loss
ALONE (no red eye) → Retinal detachment, CRAO, vitreous haemorrhage
BOTH together +
pain + mid-dilated
pupil → ACUTE ANGLE-CLOSURE GLAUCOMA (emergency!)
Clinical importance: Acute angle-closure glaucoma is an ophthalmological emergency. Every hour of delay risks permanent optic nerve damage. Treatment includes IV acetazolamide, topical timolol, pilocarpine drops, and urgent laser peripheral iridotomy.
n: Out of 60 soldiers who ate dinner, 50 of them develop symptoms of loose stool and vomiting. What is the most likely pattern of illness in this scenario? A) Propagated outbreak B) Common source outbreak C) Point source outbreak D) Mixed outbreak
point source vs common source outbreak definition epidemiology food poisoning
"Clonality with respect to isolates of microorganisms from a common source outbreak (point source spread) is an important concept in the epidemiology of infectious diseases."
"In a point source outbreak, persons are exposed over a brief time to the same source, such as a single meal or an event. The number of cases rises rapidly to a peak."
| Clue | Significance |
|---|---|
| "Ate dinner" - one specific meal | Single, defined source of exposure |
| "60 soldiers" - group exposed together | All exposed at the same place, same time |
| 50 out of 60 fell ill | High attack rate (83%) - typical of foodborne point source |
| Symptoms: loose stool + vomiting | Classic food poisoning presentation |
| Type | Definition | Epidemic Curve Shape | Example |
|---|---|---|---|
| C) Point source | All exposed to same source at one point in time | Sharp, rapid rise and fall within one incubation period | Food poisoning at a single dinner ← THIS QUESTION |
| B) Common source | Exposed to same source but over a prolonged period (continuous/intermittent) | Plateau or irregular pattern over days-weeks | Contaminated water supply used over several days |
| A) Propagated | Person-to-person transmission - each case becomes a source | Multiple peaks, each ~1 incubation period apart | Measles, influenza spreading through a school |
| D) Mixed | Starts as point/common source then spreads person-to-person | Initial sharp peak, then secondary waves | Norovirus: contaminated buffet → then person-to-person spread |
Common source outbreak
├── Point source = single exposure at ONE point in time (e.g., one dinner)
└── Continuous source = ongoing exposure over time (e.g., contaminated well)
Make a differentiation chart. On these four outbreak.
| Feature | Point Source | Common Source (Continuous) | Propagated | Mixed |
|---|---|---|---|---|
| Definition | All cases exposed to same source at a single point in time | All cases exposed to same source over a prolonged/repeated period | Spread from person to person - each case becomes a new source | Starts as point/common source, then switches to person-to-person spread |
| Exposure type | Single, brief, simultaneous | Ongoing or intermittent | No common source - transmitted between individuals | Both source exposure AND person-to-person |
| Source | One contaminated food/water/event at one time | Continuously contaminated source (e.g., water supply, ventilation) | Infected individuals | Initially a source, then human reservoir |
| Epidemic curve shape | Sharp, narrow peak - rapid rise and fall within one incubation period | Plateau or prolonged irregular pattern - cases spread over days/weeks | Multiple peaks, each separated by approximately one incubation period | Initial sharp peak followed by secondary waves |
| Attack rate | Very high (often >50%) | Moderate to high | Variable, lower initially | Variable |
| Duration | Short - ends when exposure ends | Prolonged - continues as long as source exists | Extended - continues as long as susceptible hosts exist | Extended |
| Secondary cases | None (or rare) | None from person-to-person | All cases are "secondary" | Yes - after initial source exposure |
| Classic example | Food poisoning at a single banquet/dinner (soldiers scenario) | Contaminated municipal water supply used over weeks | Measles, influenza, chickenpox spreading through a school/community | Norovirus: contaminated buffet → then spreads person-to-person |
| Incubation period | All cases fall within one incubation period range | Cases do not cluster within one incubation period | Cases appear in waves, each wave = one incubation period | First wave within incubation; subsequent waves delayed |
| Cessation | Stops spontaneously when source is removed | Continues until source is identified and removed | Requires reducing transmission (vaccination, isolation) | Requires both source removal AND transmission control |
| Epidemic curve | ▲ Sharp spike | ▬ Flat plateau | ∿ Multiple humps | ▲ then ∿ |
| Common pathogens | Staphylococcus aureus, Salmonella, Bacillus cereus, chemical toxins | Legionella, Cryptosporidium, typhoid (contaminated water) | Measles, influenza, COVID-19, Shigella | Norovirus, Hepatitis A |
| Control measure | Identify and remove the single source | Identify and eliminate the ongoing source | Break chain of transmission (isolation, vaccination) | Both source elimination AND transmission control |
POINT SOURCE COMMON SOURCE PROPAGATED MIXED
(Single exposure) (Continuous) (Person-to-person) (Both)
Cases Cases Cases Cases
│ ▲ │ ████ │ ▲ ▲ ▲ │ ▲
│ ███ │ ████ │ ███ ██ ██ │ ███ ▲▲
│█████ │█████ │████████████ │██████▲▲▲
└──────► Time └──────────► Time └──────────────► Time └────────► Time
Sharp peak Plateau/flat Multiple waves Peak then waves
within 1 over days/weeks each 1 incubation
incubation period apart
| Outbreak | Clue Word |
|---|---|
| Point source | "One dinner" / "one event" / "one time" |
| Common source | "Water supply" / "ongoing" / "weeks of cases" |
| Propagated | "Person to person" / "waves" / "community spread" |
| Mixed | "Starts at event, then spreads" / "two phases" |
Quick rule: If the question mentions a single shared meal or event → Point source. If cases keep appearing in waves separated by incubation periods → Propagated. If the source is ongoing (like a water supply) → Common source (continuous). If it starts as one then becomes the other → Mixed.
Ph of stomach
| Source | pH Value |
|---|---|
| Lippincott's Biochemistry (8th ed.) | pH 2 to 3 (gastric lumen) |
| Histology: A Text and Atlas | pH <1.0 to 2.0 (gastric juice) |
| Guyton & Hall Medical Physiology | pH ~0.8 (directly at parietal cell secretion) |
| Sabiston Textbook of Surgery | pH 0.8 (pure parietal cell secretion); lowest intraluminal pH commonly measured is around 1.0-2.0 |
| State | pH |
|---|---|
| Pure HCl from parietal cells | ~0.8 (most acidic possible) |
| Fasting/empty stomach | 1.5 - 2.0 |
| After a meal (diluted by food) | 3.0 - 5.0 (temporarily rises) |
| With antacid therapy | Can be raised to >4-6 |
| GI Segment | pH |
|---|---|
| Saliva (mouth) | 6.2 - 7.4 |
| Stomach (fasting) | 1.5 - 2.0 |
| Duodenum | 5.0 - 6.0 |
| Jejunum | 6.0 - 7.0 |
| Ileum | 7.0 - 8.0 |
| Colon | 5.5 - 7.0 |
Key exam fact: Stomach pH = 1.5 - 3.5 is the standard range given in most pharmacology and physiology exams. The parietal cells secrete pure HCl at pH ~0.8, but the intraluminal (lumen) pH after mixing is typically 1.5 - 2.0 in the fasting state.
1.5-2 2-3 which one is more correct
| Range | Context | Accuracy |
|---|---|---|
| 1.5 - 2.0 | Fasting stomach (empty) | Most correct for exams |
| 2.0 - 3.0 | After a meal / mixed with food | Correct but context-specific |
| ~0.8 | Pure HCl at parietal cell level | Too extreme for lumen pH |
| Situation | pH to Quote |
|---|---|
| Fasting / empty stomach | 1.5 - 2.0 |
| After eating | 3.0 - 5.0 |
| On proton pump inhibitor (e.g., omeprazole) | >4.0 |
| Achlorhydria (no acid) | >7.0 |
Bottom line: For MCQ/exam purposes, quote 1.5 - 2.0 as the normal fasting gastric pH. The range 2-3 is acceptable but describes a post-meal or averaged state, not the true fasting acid environment. Most pharmacology and physiology exams use 1.5 - 3.5 as the full range, with 1.5 - 2.0 as the fasting baseline.
Submental lymph nodes swelling
submental lymph nodes swelling causes drainage area clinical significance
"A single midline zone, corresponding to the submental triangle, between the two anterior bellies of digastric and the hyoid bone. The submental lymph nodes provide lymphatic drainage to the anterior floor of mouth, lower lip, and ventral tongue."
| Cause | Notes |
|---|---|
| Dental infections | Periapical abscess of lower incisors; most common cause |
| Oral cavity infections | Stomatitis, gingivitis, aphthous ulcers |
| Lip/chin skin infections | Cellulitis, impetigo, infected cuts |
| Infectious mononucleosis (EBV) | Generalised lymphadenopathy including submental |
| Actinomycosis | Cervicofacial form - "lumpy jaw" |
| Tuberculosis | Cold abscess, rubbery non-tender nodes |
| Acute tonsillitis / pharyngitis | Can involve submental indirectly |
| Primary Site | Cancer Type |
|---|---|
| Floor of mouth (anterior) | Squamous cell carcinoma - most important |
| Tip/ventral tongue | SCC - frequently metastasises here |
| Lower lip (central) | SCC |
| Chin skin | SCC, melanoma, basal cell carcinoma |
| Lower incisor gingiva | SCC |
| Metastatic from distant primary | Less common |
| Cause | Notes |
|---|---|
| Reactive lymphadenopathy | Non-specific response to minor oral trauma or infection |
| Lymphoma (Hodgkin/Non-Hodgkin) | Usually part of generalised lymphadenopathy |
| Dermoid/epidermoid cyst | Midline swelling that can mimic lymph node |
| Sarcoidosis | Rare cause of cervical lymphadenopathy |
| Feature | Suggests Benign | Suggests Malignancy |
|---|---|---|
| Tenderness | Tender (infection) | Non-tender |
| Consistency | Soft/firm | Hard, stony |
| Mobility | Mobile | Fixed/tethered |
| Surface | Smooth | Irregular |
| Onset | Acute | Gradual, weeks-months |
| Skin | May be red/warm | May show skin tethering |
| Associated | Dental pain, oral ulcer | Weight loss, dysphagia |
Any persistent, non-tender, hard submental lymph node in an adult (especially a smoker/drinker) must be investigated for oral cavity carcinoma - particularly SCC of the anterior floor of mouth or ventral tongue - until proven otherwise.
Submental lymph nodes swelling in pt how is know case of hyperthyroidism from 6 month on antithyroid medicine
antithyroid drugs carbimazole propylthiouracil lymphadenopathy side effect mechanism
| Severity | Side Effect |
|---|---|
| Mild | Pruritic rash, fever, urticaria, arthralgia |
| Serious | ANCA-associated vasculitis, hepatitis, liver failure, agranulocytosis |
"A fever and sore throat in a patient taking thionamides requires measurement of full blood count."
Patient: Hyperthyroidism + on antithyroid drug 6 months
+ Submental lymph node swelling
│
▼
Is there fever / sore throat?
│
┌─────┴──────┐
YES NO
│ │
URGENT FBC Check for rash,
(rule out arthralgia → mild
agranulocytosis) side effect or
│ ANCA vasculitis
Neutrophils
<0.5×10⁹/L?
│
STOP DRUG
Admit + IV antibiotics
G-CSF if severe
| Test | Why |
|---|---|
| Full Blood Count (FBC) | Rule out agranulocytosis - URGENT |
| ANCA titres (p-ANCA, c-ANCA) | Rule out PTU-induced vasculitis |
| LFTs | Rule out drug-induced hepatitis |
| TFTs (TSH, fT3, fT4) | Check thyroid control status |
| FNAC of lymph node | If node is hard, non-tender, progressive - rule out malignancy |
Any patient on carbimazole or PTU who develops lymph node swelling with fever or sore throat must have an urgent FBC done the same day. Agranulocytosis is life-threatening and the drug must be stopped immediately if confirmed.
What is agranulocytosis
| Threshold | Classification |
|---|---|
| Absolute Neutrophil Count (ANC) < 1500/mm³ | Neutropenia |
| ANC < 500/mm³ | Severe neutropenia |
| ANC < 100/mm³ | Agranulocytosis (profound/life-threatening) |
"Agranulocytosis = ANC < 500 cells/mm³ or WBC < 1000 cells/mm³"
"Agranulocytosis is usually a complication of medical drug use, either by a mechanism of direct chemical toxicity or by immune destruction."
| Drug Category | Examples |
|---|---|
| Antithyroid drugs | Carbimazole, propylthiouracil (PTU) - 0.2-0.5% risk |
| Antipsychotics | Clozapine (~1% risk - requires mandatory blood monitoring) |
| Antibiotics | Cotrimoxazole, chloramphenicol |
| Antiepileptics | Carbamazepine, phenytoin |
| Antirheumatics | Sulfasalazine, gold salts |
| Analgesics | Metamizole (dipyrone) |
| Chemotherapy | Virtually all cytotoxic agents |
| Antivirals | Ganciclovir, zidovudine |
Drug (e.g. carbimazole)
│
┌────┴────┐
Direct Immune
toxicity mediated
│ │
Kills bone Drug acts as hapten
marrow → antibodies against
precursors neutrophils → destruction
│ │
└─────┬─────┘
▼
Profound neutropenia
→ Unable to fight infection
→ Fever, sore throat, mouth ulcers
→ Sepsis if untreated
| Feature | Description |
|---|---|
| Fever | Often high-grade, sudden onset |
| Sore throat / mouth ulcers | Oropharyngeal infection - first sign |
| Swollen lymph nodes | Reactive to secondary infection |
| Fatigue, malaise | Systemic infection |
| Septicaemia | If untreated - can be fatal |
| No pus | Because no neutrophils to form pus |
| Step | Action |
|---|---|
| 1 | STOP the causative drug immediately |
| 2 | Hospital admission |
| 3 | Broad-spectrum IV antibiotics (empirical) |
| 4 | Reverse isolation (protect from infection) |
| 5 | G-CSF (Granulocyte Colony-Stimulating Factor, e.g. filgrastim) - stimulates bone marrow to produce neutrophils |
| 6 | Monitor FBC daily until recovery |
Prognosis: Usually reversible after stopping the drug. Harrison's confirms: "Agranulocytosis should resolve with discontinuation of exposure" - but mortality is significant if sepsis develops before diagnosis.